230 related articles for article (PubMed ID: 27400001)
1. Diagnostic Biomarkers in Women With Suspected Preeclampsia in a Prospective Multicenter Study.
Duckworth S; Griffin M; Seed PT; North R; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CWG; Shennan AH; Chappell LC
Obstet Gynecol; 2016 Aug; 128(2):245-252. PubMed ID: 27400001
[TBL] [Abstract][Full Text] [Related]
2. Screening models using multiple markers for early detection of late-onset preeclampsia in low-risk pregnancy.
Park HJ; Kim SH; Jung YW; Shim SS; Kim JY; Cho YK; Farina A; Zanello M; Lee KJ; Cha DH
BMC Pregnancy Childbirth; 2014 Jan; 14():35. PubMed ID: 24444293
[TBL] [Abstract][Full Text] [Related]
3. Prediction of imminent preeclampsia at 35-37 weeks gestation.
Ciobanu A; Wright A; Panaitescu A; Syngelaki A; Wright D; Nicolaides KH
Am J Obstet Gynecol; 2019 Jun; 220(6):584.e1-584.e11. PubMed ID: 30738886
[TBL] [Abstract][Full Text] [Related]
4. Soluble fms-like tyrosine kinase-1 and placental growth factor kinetics during and after pregnancy in women with suspected or confirmed pre-eclampsia.
Saleh L; van den Meiracker AH; Geensen R; Kaya A; Roeters van Lennep JE; Duvekot JJ; Verdonk K; Steegers EAP; Russcher H; Danser AHJ; Visser W
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):751-757. PubMed ID: 28600845
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators of severe disease in late preterm pre-eclampsia to guide decision making on timing of delivery: The PEACOCK study.
Duhig KE; Seed PT; Placzek A; Sparkes J; Hendy E; Gill C; Brockbank A; Shennan AH; Thangaratinam S; Chappell LC
Pregnancy Hypertens; 2021 Jun; 24():90-95. PubMed ID: 33770588
[TBL] [Abstract][Full Text] [Related]
6. Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dinkel C; Schoedl M; Dilba P; Hund M; Verlohren S
Obstet Gynecol; 2016 Aug; 128(2):261-269. PubMed ID: 27399996
[TBL] [Abstract][Full Text] [Related]
7. Addition of N-terminal pro-B natriuretic peptide to soluble fms-like tyrosine kinase-1/placental growth factor ratio > 38 improves prediction of pre-eclampsia requiring delivery within 1 week: a longitudinal cohort study.
Sabriá E; Lequerica-Fernández P; Lafuente-Ganuza P; Eguia-Ángeles E; Escudero AI; Martínez-Morillo E; Barceló C; Álvarez FV
Ultrasound Obstet Gynecol; 2018 Jun; 51(6):758-767. PubMed ID: 29498431
[TBL] [Abstract][Full Text] [Related]
8. Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.
Zeisler H; Llurba E; Chantraine F; Vatish M; Staff AC; Sennström M; Olovsson M; Brennecke SP; Stepan H; Allegranza D; Dilba P; Schoedl M; Hund M; Verlohren S
N Engl J Med; 2016 Jan; 374(1):13-22. PubMed ID: 26735990
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.
Yu F; Bai Q; Zhang S; Jiang Y
J Clin Lab Anal; 2019 Jun; 33(5):e22861. PubMed ID: 30758082
[TBL] [Abstract][Full Text] [Related]
10. Novel circulating placental markers prokineticin-1, soluble fms-like tyrosine kinase-1, soluble endoglin and placental growth factor and association with late miscarriage.
Jayasena CN; Abbara A; Comninos AN; Narayanaswamy S; Gonzalez Maffe J; Izzi-Engbeaya C; Oldham J; Lee TT; Sarang Z; Malik Z; Dhanjal MK; Williamson C; Regan L; Bloom SR; Dhillo WS
Hum Reprod; 2016 Dec; 31(12):2681-2688. PubMed ID: 27664209
[TBL] [Abstract][Full Text] [Related]
11. Decision Threshold for Kryptor sFlt-1/PlGF Ratio in Women With Suspected Preeclampsia: Retrospective Study in a Routine Clinical Setting.
Andersen LLT; Helt A; Sperling L; Overgaard M
J Am Heart Assoc; 2021 Sep; 10(17):e021376. PubMed ID: 34459248
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome.
Stepan H; Hund M; Gencay M; Denk B; Dinkel C; Kaminski WE; Wieloch P; Semus B; Meloth T; Dröge LA; Verlohren S
Hypertens Pregnancy; 2016 Aug; 35(3):295-305. PubMed ID: 27028698
[TBL] [Abstract][Full Text] [Related]
13. Vasoactive agents for the prediction of early- and late-onset preeclampsia in a high-risk cohort.
Villa PM; Hämäläinen E; Mäki A; Räikkönen K; Pesonen AK; Taipale P; Kajantie E; Laivuori H
BMC Pregnancy Childbirth; 2013 May; 13():110. PubMed ID: 23663420
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal changes in maternal serum placental growth factor and soluble fms-like tyrosine kinase-1 in women at increased risk of pre-eclampsia.
Khalil A; Maiz N; Garcia-Mandujano R; Penco JM; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):324-31. PubMed ID: 26387758
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
[TBL] [Abstract][Full Text] [Related]
16. [Value of second trimester maternal serum sFlt-1, PlGF and their ratio in the prediction of preeclampsia].
Gao J; Shen J; Jiang Y; Zhou X; Qi H; Liu X; Liu J; Yang J; Bian X
Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):22-5. PubMed ID: 24694913
[TBL] [Abstract][Full Text] [Related]
17. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
[TBL] [Abstract][Full Text] [Related]
18. A longitudinal analysis of angiotensin II type 1 receptor antibody and angiogenic markers in pregnancy.
Aggarwal S; Sunderland N; Thornton C; Xu B; Hennessy A; Makris A
Am J Obstet Gynecol; 2017 Feb; 216(2):170.e1-170.e8. PubMed ID: 27793555
[TBL] [Abstract][Full Text] [Related]
19. Does a sFlt-1/PlGF ratio result > 655 before 34 weeks' gestation necessitate preterm delivery within 2 days? A retrospective observational study.
Siepen C; Brennecke S
J Matern Fetal Neonatal Med; 2024 Dec; 37(1):2371047. PubMed ID: 38926094
[TBL] [Abstract][Full Text] [Related]
20. Association of increased cord blood soluble endoglin with the development of bronchopulmonary dysplasia in preterm infants with maternal preeclampsia.
Kim DH; Shin SH; Kim EK; Kim HS
Pregnancy Hypertens; 2018 Jul; 13():148-153. PubMed ID: 30177044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
